Business Description
Idogen AB
ISIN : SE0014428561
Compare
Compare
Traded in other countries / regions
IDOGEN.Sweden IPO Date
2015-06-12Description
Idogen AB is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system. Its product IDO 8, treats patients with severe hemorrhagic disease.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-EBIT | -1.15 | |||||
EV-to-Forward-EBITDA | -1.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Idogen AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.42 | ||
| Beta | 0.0952 | ||
| 3-Year Sharpe Ratio | -0.88 | ||
| 3-Year Sortino Ratio | -0.86 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (kr) | - | ||
| 20-Day SMA (kr) | 0.1205 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (kr) | 0.1205 - 0.1205 | ||
| Shares Outstanding (Mil) | 104.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Idogen AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Idogen AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Annual report for 2024 | 2025-05-09 | 0.12 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-09 | 0.12 (+0.00%) | ||
| Fourth quarter earnings results for 2024 | 2025-02-07 | 0.12 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-12-06 | 0.12 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-12-06 | 0.12 (+0.00%) | ||
| General meeting for 2023 | 2024-11-21 13:00 | 0.12 (+0.00%) | ||
| 0.1:1 Stock Split | 2020-05-27 | 5.17 (-1.59%) |
Show
Entries
Idogen AB Frequently Asked Questions
What is Idogen AB(OSTO:IDOGEN)'s stock price today?
The current price of OSTO:IDOGEN is kr0.12. The 52 week high of OSTO:IDOGEN is kr0.12 and 52 week low is kr0.12.
When is next earnings date of Idogen AB(OSTO:IDOGEN)?
The next earnings date of Idogen AB(OSTO:IDOGEN) is .
Does Idogen AB(OSTO:IDOGEN) pay dividends? If so, how much?
Idogen AB(OSTO:IDOGEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Idogen AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers